Related Experiment Video
Updated: May 27, 2026

Immunophenotyping and Cell Sorting of Human MKs from Human Primary Sources or Differentiated In Vitro from Hematopoietic Progenitors
Published on: August 7, 2021
Megakaryopoiesis and thrombopoiesis: an update on cytokines and lineage surface markers
1Laboratories of Biochemistry and Molecular Biology, The Rockefeller University New York, New York, NY, USA.
Abstract:
Megakaryopoiesis is the process by which mature megakaryocytes (MKs) develop from hematopoietic stem cells (HSCs). The biological function of MKs is to produce platelets, which play critical roles in hemostasis and contribute to angiogenesis and wound healing. The generation of platelets from MKs is termed thrombopoiesis. The cytokine thrombopoietin (TPO) is the major regulator of megakaryopoiesis and thrombopoiesis. It binds to its surface receptor, c-Mpl, and acts through multiple downstream signaling pathways, including the PI-3 kinase-Akt, MAPK, and ERK1/ERK2 pathways. However, non-TPO pathways, such as the SDF1/CXCR4 axis, Notch signaling, src family kinases, integrin signaling, and Platelet Factor 4/low-density lipoprotein receptor-related protein 1, have more recently been recognized to influence megakaryopoiesis and thrombopoiesis in vitro and in vivo. In this chapter, we review megakaryopoiesis and thrombopoiesis with emphasis on cell surface marker changes during their differentiation from HSCs, and the classical cytokines that affect these developmental stages. We also discuss non-TPO regulators and their effects on in vitro culture systems.
Insights
Megakaryopoiesis and thrombopoiesis are key blood cell development processes. This review details regulators like thrombopoietin (TPO) and emerging non-TPO pathways influencing platelet production from hematopoietic stem cells.
Area of Science:
- Hematology
- Cell Biology
- Developmental Biology
Background:
- Megakaryopoiesis is the development of megakaryocytes (MKs) from hematopoietic stem cells (HSCs).
- MKs produce platelets, essential for hemostasis, angiogenesis, and wound healing.
- Thrombopoiesis is the generation of platelets from MKs.
Purpose of the Study:
- To review megakaryopoiesis and thrombopoiesis.
- To emphasize cell surface marker changes during HSC differentiation.
- To discuss classical and non-TPO regulators of these processes.
Main Methods:
- Review of existing literature on megakaryopoiesis and thrombopoiesis.
- Emphasis on cell surface marker changes during differentiation.
- Discussion of cytokine regulation, including TPO and non-TPO pathways.
Main Results:
- Thrombopoietin (TPO) is a major regulator, acting via c-Mpl and downstream pathways (PI-3 kinase-Akt, MAPK, ERK1/ERK2).
- Non-TPO pathways (SDF1/CXCR4, Notch, src kinases, integrins, PF4/LRP1) also influence megakaryopoiesis and thrombopoiesis.
- Cell surface marker dynamics and classical cytokines are key aspects of HSC differentiation into MKs.
Conclusions:
- Understanding TPO and non-TPO regulators is crucial for comprehending megakaryopoiesis and thrombopoiesis.
- Cell surface markers provide insights into HSC differentiation stages.
- In vitro culture systems are valuable for studying these complex developmental processes.
Related Concept Videos
Lineage Commitment
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Regulation of Hematopoietic Stem Cells
Hematopoiesis
Production of Formed Elements
Most HSCs commit to...

